Some Taste Substances Are Direct Activators of G-Proteins
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Ras Gtpase Chemi ELISA Kit Catalog No
Ras GTPase Chemi ELISA Kit Catalog No. 52097 (Version B3) Active Motif North America 1914 Palomar Oaks Way, Suite 150 Carlsbad, California 92008, USA Toll free: 877 222 9543 Telephone: 760 431 1263 Fax: 760 431 1351 Active Motif Europe Waterloo Atrium Drève Richelle 167 – boîte 4 BE-1410 Waterloo, Belgium UK Free Phone: 0800 169 31 47 France Free Phone: 0800 90 99 79 Germany Free Phone: 0800 181 99 10 Telephone: +32 (0)2 653 0001 Fax: +32 (0)2 653 0050 Active Motif Japan Azuma Bldg, 7th Floor 2-21 Ageba-Cho, Shinjuku-Ku Tokyo, 162-0824, Japan Telephone: +81 3 5225 3638 Fax: +81 3 5261 8733 Active Motif China 787 Kangqiao Road Building 10, Suite 202, Pudong District Shanghai, 201315, China Telephone: (86)-21-20926090 Hotline: 400-018-8123 Copyright 2021 Active Motif, Inc. www.activemotif.com Information in this manual is subject to change without notice and does not constitute a commit- ment on the part of Active Motif, Inc. It is supplied on an “as is” basis without any warranty of any kind, either explicit or implied. Information may be changed or updated in this manual at any time. This documentation may not be copied, transferred, reproduced, disclosed, or duplicated, in whole or in part, without the prior written consent of Active Motif, Inc. This documentation is proprietary information and protected by the copyright laws of the United States and interna- tional treaties. The manufacturer of this documentation is Active Motif, Inc. © 2021 Active Motif, Inc., 1914 Palomar Oaks Way, Suite 150; Carlsbad, CA 92008. -
Popular Sweeteners and Their Health Effects Based Upon Valid Scientific Data
Popular Sweeteners and Their Health Effects Interactive Qualifying Project Report Submitted to the Faculty of the WORCESTER POLYTECHNIC INSTITUTE in partial fulfillment of the requirements for the Degree of Bachelor of Science By __________________________________ Ivan Lebedev __________________________________ Jayyoung Park __________________________________ Ross Yaylaian Date: Approved: __________________________________ Professor Satya Shivkumar Abstract Perceived health risks of artificial sweeteners are a controversial topic often supported solely by anecdotal evidence and distorted media hype. The aim of this study was to examine popular sweeteners and their health effects based upon valid scientific data. Information was gathered through a sweetener taste panel, interviews with doctors, and an on-line survey. The survey revealed the public’s lack of appreciation for sweeteners. It was observed that artificial sweeteners can serve as a low-risk alternative to natural sweeteners. I Table of Contents Abstract .............................................................................................................................................. I Table of Contents ............................................................................................................................... II List of Figures ................................................................................................................................... IV List of Tables ................................................................................................................................... -
H-Ras Gtpase
H-Ras GTPase Key to Understanding Cancer? Marquette University High School SMART Team: Mohammed Ayesh, Wesley Borden, Andrew Bray, Brian Digiacinto, Patrick Jordan, David Moldenhauer, Thomas Niswonger, Joseph Radke, Amit Singh, Alex Vincent, and Caleb Vogt Teachers: Keith Klestinski and David Vogt Mentor: Evgenii Kovrigin, Ph.D., Medical College of Wisconsin Abstract Cell Cycle Control The protein known as H-Ras GTPase is essential to H-ras is activated late in the G1 phase. proper biological functioning in the entire web of life. The Once H-ras is activated, the cell advances main function of this protein is giving the "stop" signal to past the G1 checkpoint and is compelled to the process of cell reproduction. Unfortunately, this protein complete mitosis. is not perfect and severe consequences, such as cancer, can arise when H-Ras GTPase malfunctions. H-Ras GTPase is a protein from the large family of enzymes that bind and split GTP. H-Ras GTPase is vital in processes like cell-to-cell communication, protein translation in ribosomes, and programmed cell death Ras GTPase Ras GDPase (apoptosis). Its main fields of operation are determining Active Inactive stem cell into specific functioning cells, as well as replicating preexisting "specialized" cells. All G domain based proteins have a universal structure and two Controlling the “Switch” between universal switch mechanisms, which consist of a mixed, six-stranded beta sheet and five alpha helices. H-Ras Active and Inactive States GTPase works by first dissociating from GDP and binding In the graphics (above and below), H-ras is shown in both © 2008, Physiomics, Corp. -
Appendix 2. Significantly Differentially Regulated Genes in Term Compared with Second Trimester Amniotic Fluid Supernatant
Appendix 2. Significantly Differentially Regulated Genes in Term Compared With Second Trimester Amniotic Fluid Supernatant Fold Change in term vs second trimester Amniotic Affymetrix Duplicate Fluid Probe ID probes Symbol Entrez Gene Name 1019.9 217059_at D MUC7 mucin 7, secreted 424.5 211735_x_at D SFTPC surfactant protein C 416.2 206835_at STATH statherin 363.4 214387_x_at D SFTPC surfactant protein C 295.5 205982_x_at D SFTPC surfactant protein C 288.7 1553454_at RPTN repetin solute carrier family 34 (sodium 251.3 204124_at SLC34A2 phosphate), member 2 238.9 206786_at HTN3 histatin 3 161.5 220191_at GKN1 gastrokine 1 152.7 223678_s_at D SFTPA2 surfactant protein A2 130.9 207430_s_at D MSMB microseminoprotein, beta- 99.0 214199_at SFTPD surfactant protein D major histocompatibility complex, class II, 96.5 210982_s_at D HLA-DRA DR alpha 96.5 221133_s_at D CLDN18 claudin 18 94.4 238222_at GKN2 gastrokine 2 93.7 1557961_s_at D LOC100127983 uncharacterized LOC100127983 93.1 229584_at LRRK2 leucine-rich repeat kinase 2 HOXD cluster antisense RNA 1 (non- 88.6 242042_s_at D HOXD-AS1 protein coding) 86.0 205569_at LAMP3 lysosomal-associated membrane protein 3 85.4 232698_at BPIFB2 BPI fold containing family B, member 2 84.4 205979_at SCGB2A1 secretoglobin, family 2A, member 1 84.3 230469_at RTKN2 rhotekin 2 82.2 204130_at HSD11B2 hydroxysteroid (11-beta) dehydrogenase 2 81.9 222242_s_at KLK5 kallikrein-related peptidase 5 77.0 237281_at AKAP14 A kinase (PRKA) anchor protein 14 76.7 1553602_at MUCL1 mucin-like 1 76.3 216359_at D MUC7 mucin 7, -
Reports of the Scientific Committee for Food
Commission of the European Communities food - science and techniques Reports of the Scientific Committee for Food (Sixteenth series) Commission of the European Communities food - science and techniques Reports of the Scientific Committee for Food (Sixteenth series) Directorate-General Internal Market and Industrial Affairs 1985 EUR 10210 EN Published by the COMMISSION OF THE EUROPEAN COMMUNITIES Directorate-General Information Market and Innovation Bâtiment Jean Monnet LUXEMBOURG LEGAL NOTICE Neither the Commission of the European Communities nor any person acting on behalf of the Commission is responsible for the use which might be made of the following information This publication is also available in the following languages : DA ISBN 92-825-5770-7 DE ISBN 92-825-5771-5 GR ISBN 92-825-5772-3 FR ISBN 92-825-5774-X IT ISBN 92-825-5775-8 NL ISBN 92-825-5776-6 Cataloguing data can be found at the end of this publication Luxembourg, Office for Official Publications of the European Communities, 1985 ISBN 92-825-5773-1 Catalogue number: © ECSC-EEC-EAEC, Brussels · Luxembourg, 1985 Printed in Luxembourg CONTENTS Page Reports of the Scientific Committee for Food concerning - Sweeteners (Opinion expressed 14 September 1984) III Composition of the Scientific Committee for Food P.S. Elias A.G. Hildebrandt (vice-chairman) F. Hill A. Hubbard A. Lafontaine Mne B.H. MacGibbon A. Mariani-Costantini K.J. Netter E. Poulsen (chairman) J. Rey V. Silano (vice-chairman) Mne A. Trichopoulou R. Truhaut G.J. Van Esch R. Wemig IV REPORT OF THE SCIENTIFIC COMMITTEE FOR FOOD ON SWEETENERS (Opinion expressed 14 September 1984) TERMS OF REFERENCE To review the safety in use of certain sweeteners. -
A Review on Potential Toxicity of Artificial Sweetners Vs Safety of Stevia: a Natural Bio-Sweetner
Journal of Biology, Agriculture and Healthcare www.iiste.org ISSN 2224-3208 (Paper) ISSN 2225-093X (Online) Vol.4, No.15, 2014 A Review on Potential Toxicity of Artificial Sweetners vs Safety of Stevia: A Natural Bio-Sweetner Ahmad Saad Department of Plant Breeding and Genetics. University of Agriculture Faisalabad, Pakistan E-mail: [email protected] Farooq Ahmad Khan Associate professor, Department of Plant Breeding and Genetics University of Agriculture Faisalabad, Pakistan Abdul Hayee Seed Analyst, Federal Seed Certification and Registration Department Muhammad Sajjad Nazir Department of Plant Breeding and Genetics., University of Agriculture Faisalabad Abstract Artificial sweeteners have increasingly become an area of controversy in the world of food and nutrition. Consumers are oftenly barraged with a number of contradictory opinions and reports regarding the safety and efficacy of sweeteners. Artificial sweetener consumption may cause migraines or headache, skin eruptions, muscle dysfunction, depression, weight gain, liver and kidney effects, multiple sclerosis and blurred vision. But on the other hand natural sweetners like stevia and its products are safe and don’t cause any health problem. So it’s important for the consumer to choose sweeteners with great care. Keywords: Stevia, Artificial Sweeteners, Health Problems, Natural Sweetners, Safety Issues. Objectives Based on valid research, this review aims to provide concrete information on the effects associated with consumption of artificial sweeteners in comparison with stevia which is natural and no side effects on human health. Much anecdotal information is available regarding the effects of artificial sweeteners on human health. A proper understanding regarding effects of sweetners on human health and the difference between natural and artificial sweeteners will help readers and consumers to construct a healthy diet plan and select more suitable sweetners for daily life consumption. -
Small Gtpase Ran and Ran-Binding Proteins
BioMol Concepts, Vol. 3 (2012), pp. 307–318 • Copyright © by Walter de Gruyter • Berlin • Boston. DOI 10.1515/bmc-2011-0068 Review Small GTPase Ran and Ran-binding proteins Masahiro Nagai 1 and Yoshihiro Yoneda 1 – 3, * highly abundant and strongly conserved GTPase encoding ∼ 1 Biomolecular Dynamics Laboratory , Department a 25 kDa protein primarily located in the nucleus (2) . On of Frontier Biosciences, Graduate School of Frontier the one hand, as revealed by a substantial body of work, Biosciences, Osaka University, 1-3 Yamada-oka, Suita, Ran has been found to have widespread functions since Osaka 565-0871 , Japan its initial discovery. Like other small GTPases, Ran func- 2 Department of Biochemistry , Graduate School of Medicine, tions as a molecular switch by binding to either GTP or Osaka University, 2-2 Yamada-oka, Suita, Osaka 565-0871 , GDP. However, Ran possesses only weak GTPase activ- Japan ity, and several well-known ‘ Ran-binding proteins ’ aid in 3 Japan Science and Technology Agency , Core Research for the regulation of the GTPase cycle. Among such partner Evolutional Science and Technology, Osaka University, 1-3 molecules, RCC1 was originally identifi ed as a regulator of Yamada-oka, Suita, Osaka 565-0871 , Japan mitosis in tsBN2, a temperature-sensitive hamster cell line (3) ; RCC1 mediates the conversion of RanGDP to RanGTP * Corresponding author in the nucleus and is mainly associated with chromatin (4) e-mail: [email protected] through its interactions with histones H2A and H2B (5) . On the other hand, the GTP hydrolysis of Ran is stimulated by the Ran GTPase-activating protein (RanGAP) (6) , in con- Abstract junction with Ran-binding protein 1 (RanBP1) and/or the large nucleoporin Ran-binding protein 2 (RanBP2, also Like many other small GTPases, Ran functions in eukaryotic known as Nup358). -
Determination of Sodium N-Cyclohexylsulfamate in Food
Determination of sodium N-cyclohexylsulfamate in food Author Chromatogram Ping Wang, SinoUnison Technology Co., Ltd Experimental background Sodium N-cyclohexylsulfamate, also known as "Sodium cyclamate", is commonly used as food sweeteners in food prodution. It is a non-nutritional sweetener with the sweetness that is 30-40 times of regular table sugar. It serves as an internationally accepted food additives that can be used in refreshing beverages, juices, ice cream, pastry food, preserved fruit, etc. If consumers often have beverages or other foods with excess sweetener content, it may harm the liver and nervous system due to excessive intake. Figure 1: Standard chromatogram of sodium cyclamate. At present, the detection methods of food sweetener content include: LC, GC, LC-MS, ion-exchange Results chromatography, etc. This method refers to "GB/T 5009.97-2016 determination of Sodium N- cyclohexylsulfamate in food". The sample was extrated with water, followed by reaction with sodium hypochlorite in strong acidic solution, forming N,N- Dichlorocyclohexanamine. High performance liquid chromatography (HPLC) was used for analysis after extraction with n-heptane. Retention time is used for Conclusion qualitative analysis, and external reference method is This method uses SVEA C18 Gold 5μm 110Å 250*4.6mm used for quantitive analysis. HPLC Column for the analysis of Sodium cyclamate. The Experimental analysis only takes 10min. This method is fast and simple with reliable results and good reproducibility. The Column: SVEA C18 Gold 5μm 110Å 4.6*250mm recovery rate is between 80%-110% that is suitable for Instrument: HPLC most analysis of sodium cyclamate in foods. Mobile phase: Methanol:water=90:10(v:v) Flow rate: 1.0 mL/min Column temperature: 35 °C Detector: UV 314 nm Extractant: Water Injection volume: 10μL Analyte: Sodium cyclamate 10 μg/mL Nanologica AB (publ)|556664-5023|Forskargatan 20G, SE- 151 36 Södertälje, Sweden|[email protected] . -
GTP-Binding Proteins • Heterotrimeric G Proteins
GTP-binding proteins • Heterotrimeric G proteins • Small GTPases • Large GTP-binding proteins (e.g. dynamin, guanylate binding proteins, SRP- receptor) GTP-binding proteins Heterotrimeric G proteins Subfamily Members Prototypical effect Gs Gs, Golf cAMP Gi/o Gi, Go, Gz cAMP , K+-current Gq Gq, G11, G14, Inositol trisphosphate, G15/16 diacylglycerol G12/13 G12, G13 Cytoskeleton Transducin Gt, Gustducin cGMP - phosphodiesterase Offermanns 2001, Oncogene GTP-binding proteins Small GTPases Family Members Prototypical effect Ras Ras, Rap, Ral Cell proliferation; Cell adhesion Rho Rho, Rac, CDC42 Cell shape change & motility Arf/Sar Arf, Sar, Arl Vesicles: fission and fusion Rab Rab (1-33) Membrane trafficking between organelles Ran Ran Nuclear membrane plasticity Nuclear import/export The RAB activation-inactivation cycle REP Rab escort protein GGT geranylgeranyl-transferase GDI GDP-dissociation inhibitor GDF GDI displacementfactor Lipid e.g. RAS e.g. ARF1 modification RAB, Gi/o of GTP-binding proteins Lipid modification Enzyme Reaction Myristoylation N-myristoyl-transferase myristoylates N-terminal glycin Farnesylation Farnesyl-transferase, Transfers prenyl from prenyl-PPi Geranylgeranylation geranylgeranyltransferase to C-terminal CAAX motif Palmitoylation DHHC protein Cysteine-S-acylation General scheme of coated vesicle formation T. J. Pucadyil et al., Science 325, 1217-1220 (2009) Published by AAAS General model for scission of coated buds T. J. Pucadyil et al., Science 325, 1217-1220 (2009) Published by AAAS Conformational change in Arf1 and Sar1 GTPases, regulators of coated vesicular transport This happens if protein is trapped in the active conformation Membrane tubules formed by GTP- bound Arf1 Membrane tubules formed by GTP-bound Sar1 Published by AAAS T. -
A1207 Rebaudioside M As a Steviol Glycoside from Saccharomyces Cerevisiae
21 October 2020 [138-20] Supporting document 1 Risk and technical assessment report – Application A1207 Rebaudioside M as a Steviol Glycoside from Saccharomyces cerevisiae Executive summary This application from Amyris Inc. seeks permission in the Australia New Zealand Food Standards Code (the Code) for rebaudioside M (Reb M) produced from a genetically modified (GM) Saccharomyces cerevisiae strain. Permitted steviol glycoside preparations are required to conform to a relevant specification in Schedule 3 of the Code, but the applicant’s Reb M currently does not, due to the different method of production. The food technology assessment concludes that Amyris’s Reb M produced from the applicant’s production strain of S. cerevisiae expressing steviol glycoside biosynthesis pathway genes meets the purity parameters of specifications currently listed in the Code – but not the specific method of production. These parameters are also consistent with international purity specifications for steviol glycosides. Its technological purpose matches that of permitted steviol glycoside preparations produced by the currently permitted methods and meets the proposed purpose as an intense sweetener food additive. The host S. cerevisiae strain is neither pathogenic nor toxigenic and has a long history of food use. Analysis of the production strain confirmed the presence and stability of the inserted DNA. The final product does not contain residual protein or DNA and does not give rise to any allergen concerns. An acceptable daily intake (ADI) of 0-4 mg/kg bodyweight for steviol glycosides, expressed as steviol, was established by FSANZ in 2008. This ADI is appropriate for Reb M produced from fermentation, as it is chemically the same as Reb M extracted traditionally from the leaves of S. -
Small Gtpases of the Ras and Rho Families Switch On/Off Signaling
International Journal of Molecular Sciences Review Small GTPases of the Ras and Rho Families Switch on/off Signaling Pathways in Neurodegenerative Diseases Alazne Arrazola Sastre 1,2, Miriam Luque Montoro 1, Patricia Gálvez-Martín 3,4 , Hadriano M Lacerda 5, Alejandro Lucia 6,7, Francisco Llavero 1,6,* and José Luis Zugaza 1,2,8,* 1 Achucarro Basque Center for Neuroscience, Science Park of the Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU), 48940 Leioa, Spain; [email protected] (A.A.S.); [email protected] (M.L.M.) 2 Department of Genetics, Physical Anthropology, and Animal Physiology, Faculty of Science and Technology, UPV/EHU, 48940 Leioa, Spain 3 Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Granada, 180041 Granada, Spain; [email protected] 4 R&D Human Health, Bioibérica S.A.U., 08950 Barcelona, Spain 5 Three R Labs, Science Park of the UPV/EHU, 48940 Leioa, Spain; [email protected] 6 Faculty of Sport Science, European University of Madrid, 28670 Madrid, Spain; [email protected] 7 Research Institute of the Hospital 12 de Octubre (i+12), 28041 Madrid, Spain 8 IKERBASQUE, Basque Foundation for Science, 48013 Bilbao, Spain * Correspondence: [email protected] (F.L.); [email protected] (J.L.Z.) Received: 25 July 2020; Accepted: 29 August 2020; Published: 31 August 2020 Abstract: Small guanosine triphosphatases (GTPases) of the Ras superfamily are key regulators of many key cellular events such as proliferation, differentiation, cell cycle regulation, migration, or apoptosis. To control these biological responses, GTPases activity is regulated by guanine nucleotide exchange factors (GEFs), GTPase activating proteins (GAPs), and in some small GTPases also guanine nucleotide dissociation inhibitors (GDIs). -
Sodium Cyclamate
SODIUM CYCLAMATE Prepared at the 46th JECFA (1996), published in FNP 52 Add 4 (1996) superseding specifications prepared at the 24th JECFA (1980), published in FNP 17 (1980). Metals and arsenic specifications revised at the 63rd JECFA (2004). A group ADI of 0-11 mg/kg bw for cyclamic acid and its calcium and sodium salts (as cyclamic acid) was established at the 26th JECFA (1982) SYNONYMS INS No. 952(iv) DEFINITION Chemical names Sodium cyclohexylsulfamate, sodium cyclohexanesulfamate C.A.S. number 139-05-9 Chemical formula C6H12NNaO3S Structural formula Formula weight 201.22 Assay Not less than 98.0% and not more than 101.0% on the dried basis DESCRIPTION White colourless crystals or crystalline powder FUNCTIONAL USES Sweetener CHARACTERISTICS IDENTIFICATION Solubility (Vol. 4) Soluble in water, practically insoluble in ethanol Precipitate formation To 10 ml of a 1 in 100 solution of the sample add 1 ml of hydrochloric acid TS, mix, add 1 ml of barium chloride TS. The solution remains clear, but upon the addition of 1 ml sodium nitrite TS, a white precipitate is formed Test for sodium (Vol. 4) Passes test PURITY Loss on drying (Vol. 4) Not more than 1.0% (105o, 1 h) Cyclohexylamine (Vol. 4) Not more than 10 mg/kg Transfer 25 g of the sample into a 100 ml volumetric flask, dissolve in water, dilute to volume with water, and mix. Use this solution as the test preparation. Dicyclohexylamine Not more than 1 mg/kg (Vol. 4) Lead (Vol. 4) Not more than 1 mg/kg Determine using an atomic absorption technique appropriate to the specified level.